Illustration of HLA-DR
HLA-DR5 (DR5) is a broad-antigen serotype that is further split into HLA-DR11 and HLA-DR12 antigen serotypes.
Serology
| DRB1* | DR11 | DR5 | DR12 | Sample |
| allele | % | % | % | size (N) |
| 11:01 | 92 | 5 | 3474 | |
| 11:02 | 89 | 3 | 430 | |
| 11:03 | 89 | 4 | 397 | |
| 11:04 | 87 | 4 | 2119 | |
| 11:05 | 75 | 4 | ||
| 11:06 | 20 | 73 | 15 | |
| 11:07 | >50 | 1 | ||
| 11:08 | >50 | 2 | ||
| 11:09 | 80 | 20 | 5 | |
| . | ||||
| DR12 | DR5 | DR11 | Sample | |
| 12:01 | 83 | 4 | 2 | 893 [2] |
| 12:02 | 89 | 162 | ||
| 12:03 | >50 | 3 | ||
| 12:06 | >50 | 2 | ||
Except for a few DRB1* alleles, the reactivity of DR5 is relatively poor.
Disease associations
DR5 is associated with persistent generalized lymphadenopathy[3] and Kaposi's sarcoma in AIDS,[4] juvenile rheumatoid arthritis,[5][6] pernicious anemia, Hashimoto's thyroiditis,[7][8] mycosis fungoides,[9] polyglandular deficiency syndrome,[10] systemic sclerosis,[11][12] childhood epilepsy,[13] early-onset alopecia areata,[14] short-ragweed Ra6 allergy,[15] primary antiphospholipid syndrome,[16] and increased longevity in the Dutch.[17]
Genetic linkage
HLA-DR5 reactive gene products are linked to serology of HLA-DRB3 (HLA-DR52).
References
- ↑ derived from IMGT/HLA
- ↑ DR8 - 2%
- ↑ Raffoux C, David V, Couderc L, Rabian C, Clauvel J, Seligmann M, Colombani J (1987). "HLA-A, B and DR antigen frequencies in patients with AIDS-related persistent generalized lymphadenopathy (PGL) and thrombocytopenia". Tissue Antigens. 29 (1): 60–2. doi:10.1111/j.1399-0039.1987.tb01550.x. PMID 3495904.
- ↑ Pollack M, Safai B, Myskowski P, Gold J, Pandey J, Dupont B (1983). "Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma". Tissue Antigens. 21 (1): 1–8. doi:10.1111/j.1399-0039.1983.tb00364.x. PMID 6601312.
- ↑ Førre O, Dobloug J, Høyeraal H, Thorsby E (1983). "HLA antigens in juvenile arthritis. Genetic basis for the different subtypes". Arthritis Rheum. 26 (1): 35–8. doi:10.1002/art.1780260106. PMID 6401993.
- ↑ Suciu-Foca N, Jacobs J, Godfrey M, Woodward K, Khan R, Reed E, Rohowsky C (1980). "HLA-DR5 in juvenile rheumatoid arthritis confined to few joints". Lancet. 2 (8184): 40. doi:10.1016/S0140-6736(80)92920-7. PMID 6104257. S2CID 40329624.
- ↑ Farid N, Sampson L, Moens H, Barnard J (1981). "The association of goitrous autoimmune thyroiditis with HLA-DR5". Tissue Antigens. 17 (3): 265–8. doi:10.1111/j.1399-0039.1981.tb00700.x. PMID 6947505.
- ↑ Schleusener H, Schernthaner G, Mayr W, Kotulla P, Bogner U, Finke R, Meinhold H, Koppenhagen K, Wenzel K (1983). "HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter". J Clin Endocrinol Metab. 56 (4): 781–5. doi:10.1210/jcem-56-4-781. PMID 6131902.
- ↑ Safai B, Myskowski P, Dupont B, Pollack M (1983). "Association of HLA-DR5 with mycosis fungoides". J Invest Dermatol. 80 (5): 395–7. doi:10.1111/1523-1747.ep12553615. PMID 6601679.
- ↑ Shapiro M, Zamir R, Weiss E, Radnay J, Shenkman L (1987). "The polyglandular deficiency syndrome: a new variant in Persian Jews". J Endocrinol Invest. 10 (1): 1–7. doi:10.1007/bf03347139. PMID 3496374. S2CID 33773103.
- ↑ Pereira S, Black C, Welsh K, Ansell B, Jayson M, Maddison P, Rowell N (1987). "Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families". J Rheumatol. 14 (4): 760–5. PMID 3499513.
- ↑ Luderschmidt C, Scholz S, Mehlhaff E, König G, Albert E (1987). "Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles". Arch Dermatol. 123 (9): 1188–91. doi:10.1001/archderm.123.9.1188. PMID 3498440.
- ↑ Minev M, Martinova F, Belopitova L (1987). "On the association of the HLA system with epilepsy in children". Epilepsia. 28 (1): 74–6. doi:10.1111/j.1528-1157.1987.tb03626.x. PMID 3098558. S2CID 12471018.
- ↑ Orecchia G, Belvedere M, Martinetti M, Capelli E, Rabbiosi G (1987). "Human leukocyte antigen region involvement in the genetic predisposition to alopecia areata". Dermatologica. 175 (1): 10–4. doi:10.1159/000248775. PMID 3497062.
- ↑ Marsh D, Freidhoff L, Ehrlich-Kautzky E, Bias W, Roebber M (1987). "Immune responsiveness to Ambrosia artemisiifolia (short ragweed) pollen allergen Amb a VI (Ra6) is associated with HLA-DR5 in allergic humans". Immunogenetics. 26 (4–5): 230–6. doi:10.1007/BF00346517. PMID 3498688. S2CID 25679118.
- ↑ Vargas-Alarcon G, Granados J, Bekker C, Alcocer-Varela J, Alarcón-Segovia D (1995). "Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients". Arthritis Rheum. 38 (9): 1340–1. doi:10.1002/art.1780380925. PMID 7575732.
- ↑ Lagaay A, D'Amaro J, Ligthart G, Schreuder G, van Rood J, Hijmans W (1991). "Longevity and heredity in humans. Association with the human leucocyte antigen phenotype". Ann N Y Acad Sci. 621: 78–89. doi:10.1111/j.1749-6632.1991.tb16970.x. PMID 1859103. S2CID 83560622.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.